Dr. William Cho is a renowned researcher in the Department of Clinical Oncology, China, specializing in biochemistry, molecular oncology, cancer biomarkers, and translational cancer research. He obtained his B.S. and M.S. in Biochemistry from The Chinese University of Hong Kong and earned his Ph.D. in Biochemistry from Hong Kong Baptist University.

His research focuses on cancer genomics, molecular diagnostics, precision oncology, microRNA biology, proteomics, targeted therapies, and biomarker discovery. He has made significant contributions to advancing cancer diagnosis, prognosis, and personalized treatment through multidisciplinary research.

He has authored numerous highly cited publications in leading international journals, including Molecular Cancer Therapeutics, Scientific Reports, Autophagy, Future Oncology, Expert Opinion on Therapeutic Targets, and Expert Review of Proteomics. His research spans colorectal, lung, gastric, nasopharyngeal, and pediatric cancers, as well as circulating tumor DNA, clinical proteomics, and drug resistance. He continues to contribute significantly to the advancement of precision medicine and innovative cancer therapeutics through his impactful research.

• Cancer Biomarkers – Discovery and validation of diagnostic, prognostic, and predictive biomarkers.
• Precision Oncology – Personalized cancer diagnosis and targeted treatment strategies.
• Molecular Oncology – Molecular mechanisms underlying cancer initiation, progression, and metastasis.
• Cancer Genomics and Epigenetics – Gene expression, DNA methylation, and genomic profiling in cancer.
• MicroRNA (miRNA) Research – The role of microRNAs in cancer development and therapeutic targeting.